Literature DB >> 10933640

Modulation of fluconazole sensitivity by the interaction of mitochondria and erg3p in Saccharomyces cerevisiae.

D P Kontoyiannis1.   

Abstract

We studied the effects of fluconazole, an ergosterol-depleting agent, in Saccharomyces cerevisiae, a genetically tractable fungus closely related to Candida albicans. The wild-type Saccharomyces strain was sensitive to fluconazole, but the isogenic cytoplasmic petite mutant (rho-) was resistant. The mechanism of resistance of rho- mutants appeared to involve uncoupling of oxidative phosphorylation. However, the petite strain with a mutation in cent5, 6 desaturase (erg3 rho-) was sensitive to fluconazole, in contrast to its erg3 rho+ counterpart. It is known that erg3 mutants are azole resistant through the accumulation of 14-methyl-fecosterol, a less toxic ergosterol intermediate. These results indicate that mitochondria function as important physiological partners with Erg3p in the accumulation of toxic sterol intermediates in the presence of azoles.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10933640     DOI: 10.1093/jac/46.2.191

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  27 in total

1.  Calcineurin is essential for survival during membrane stress in Candida albicans.

Authors:  M Cristina Cruz; Alan L Goldstein; Jill R Blankenship; Maurizio Del Poeta; Dana Davis; Maria E Cardenas; John R Perfect; John H McCusker; Joseph Heitman
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

2.  Transcriptional response of Candida albicans biofilms following exposure to 2-amino-nonyl-6-methoxyl-tetralin muriate.

Authors:  Rong-mei Liang; Yong-bing Cao; You-jun Zhou; Yi Xu; Ping-hui Gao; Bao-di Dai; Feng Yang; Hui Tang; Yuan-ying Jiang
Journal:  Acta Pharmacol Sin       Date:  2010-04-12       Impact factor: 6.150

3.  Mechanisms of azole resistance in a clinical isolate of Candida tropicalis.

Authors:  Patrick Vandeputte; Gérald Larcher; Thierry Bergès; Gilles Renier; Dominique Chabasse; Jean-Philippe Bouchara
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

Review 4.  Biology of the pathogenic yeast Candida glabrata.

Authors:  A Bialková; J Subík
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

5.  Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae.

Authors:  Laura Y Young; Christina M Hull; Joseph Heitman
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

6.  Functional characterization of the CgPGS1 gene reveals a link between mitochondrial phospholipid homeostasis and drug resistance in Candida glabrata.

Authors:  Monika Batova; Silvia Borecka-Melkusova; Maria Simockova; Vladimira Dzugasova; Eduard Goffa; Julius Subik
Journal:  Curr Genet       Date:  2008-03-15       Impact factor: 3.886

7.  Structural and functional study of YER067W, a new protein involved in yeast metabolism control and drug resistance.

Authors:  Tatiana Domitrovic; Guennadi Kozlov; João Claudio Gonçalves Freire; Claudio Akio Masuda; Marcius da Silva Almeida; Mónica Montero-Lomeli; Georgia Correa Atella; Edna Matta-Camacho; Kalle Gehring; Eleonora Kurtenbach
Journal:  PLoS One       Date:  2010-06-17       Impact factor: 3.240

8.  Functional genomic analysis of fluconazole susceptibility in the pathogenic yeast Candida glabrata: roles of calcium signaling and mitochondria.

Authors:  Rupinder Kaur; Irene Castaño; Brendan P Cormack
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

9.  Mechanisms of azole resistance in petite mutants of Candida glabrata.

Authors:  Sophie Brun; Thierry Bergès; Pascal Poupard; Carole Vauzelle-Moreau; Gilles Renier; Dominique Chabasse; Jean-Philippe Bouchara
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

10.  Hypersusceptibility to azole antifungals in a clinical isolate of Candida glabrata with reduced aerobic growth.

Authors:  Patrick Vandeputte; Guy Tronchin; Françoise Rocher; Gilles Renier; Thierry Bergès; Dominique Chabasse; Jean-Philippe Bouchara
Journal:  Antimicrob Agents Chemother       Date:  2009-04-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.